Canada markets closed

Champions Oncology, Inc. (CSBR)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.13+0.23 (+4.69%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 69.74M
Enterprise Value 73.01M
Trailing P/E 458.00
Forward P/E 22.88
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.41
Price/Book (mrq)6.77
Enterprise Value/Revenue 1.48
Enterprise Value/EBITDA -10.73

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 35.18%
S&P500 52-Week Change 322.38%
52 Week High 37.32
52 Week Low 34.17
50-Day Moving Average 35.25
200-Day Moving Average 35.77

Share Statistics

Avg Vol (3 month) 33.6k
Avg Vol (10 day) 31.6k
Shares Outstanding 513.59M
Implied Shares Outstanding 613.59M
Float 84.72M
% Held by Insiders 125.55%
% Held by Institutions 142.22%
Shares Short (Apr 15, 2024) 456.51k
Short Ratio (Apr 15, 2024) 417.26
Short % of Float (Apr 15, 2024) 40.82%
Short % of Shares Outstanding (Apr 15, 2024) 40.42%
Shares Short (prior month Mar 15, 2024) 462.58k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Aug 12, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Apr 30, 2023
Most Recent Quarter (mrq)Jan 31, 2024

Profitability

Profit Margin -19.76%
Operating Margin (ttm)-21.44%

Management Effectiveness

Return on Assets (ttm)-17.48%
Return on Equity (ttm)-388.65%

Income Statement

Revenue (ttm)49.22M
Revenue Per Share (ttm)3.63
Quarterly Revenue Growth (yoy)-5.90%
Gross Profit (ttm)N/A
EBITDA -6.33M
Net Income Avi to Common (ttm)-9.73M
Diluted EPS (ttm)-0.72
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.47M
Total Cash Per Share (mrq)0.33
Total Debt (mrq)7.74M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.60
Book Value Per Share (mrq)-0.15

Cash Flow Statement

Operating Cash Flow (ttm)-5.01M
Levered Free Cash Flow (ttm)-3.13M